Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Manipal Academy of Higher Education
Eligibility
Inclusion criteria
Inclusion criteria: HIV seropositive patients (HIV-SPP) of either sex on INSTI-based and other ART therapies, from both in-patient and out-patient departments of the study center.
Exclusion criteria
Exclusion criteria: 1. HIV-SPP who refused ART treatment and did not consent to participate in the study. 2. HIV-SPP taking only herbal medicines and medications belonging to Ayurvedic, Homeopathic, Siddha, and Unani treatments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The identification, assessment, and documentation of all PDDIs within INSTI-based ART therapy and between ART and other therapies in HIV patients. To establish the reduced incidence of DDIs in the INSTI-based ART regimens, compared to other ART regimens. To report the Incidence and Prevalence rates of the established PDDIs, their mechanism(s), and outline the management.Timepoint: Patient files will be screened at the Baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| To report the Incidence and Prevalence rates of the established PDDIs, their mechanism(s), and outline the management.Timepoint: Patient files will be screened at the Baseline. | — |
Countries
India
Contacts
Public ContactAieshel Serafin Johnson
Department of Pharmacy Practice, Manipal College of Pharmacy Practice
Outcome results
None listed